Mission statement · Company scope
“Our mission is to develop novel therapeutics to treat rare, chronic, and serious infectious diseases in areas of high unmet medical need.”
In use2022 – now1 sighting
First seenMar 2022Added
Last seenMar 2022Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Innovation · Problem–solution
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 22 words · reading grade 13.9
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_3a7e3de68f77397d
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2022-03-28 · sec_sentence · 424B4 · accession 0001193125-22-085459
View filing ↗0 to compareCompare